-
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
28 Mar 2025 12:00 GMT
Marlton, NJ, March 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it received European CE Mark approval for an expanded …
-
The Effect of Recombinant Human Brain Natriuretic Peptide Combined with Xinmailong on Heart Failure and Its Impact on Cardiac Function and Inflammatory Response
07 Apr 2025 17:09 GMT
… into systolic heart failure and diastolic heart failure. As the disease progresses, heart …
-
Diastolic Heart Failure Drug Market by Technology, Product, Application, and Geography - Forecast and Analysis 2024-2032
17 Oct 2024 10:58 GMT
… & Countries Mentioned In Diastolic Heart Failure Drug Market Report:
‣ … ‣ Latin America ( Brazil)
Introduction:
Diastolic heart failure, or heart failure with preserved … covered in the worldwide Diastolic Heart Failure Drug market analysis.
• …
-
JK-07 by Salubris Biotherapeutics for Diastolic Heart Failure (HFpEF): Likelihood of Approval
04 Jan 2024 21:36 GMT
… failure with preserved ejection fraction (diastolic heart failure). It is administered through intravenous …
-
MYK-224 by Bristol-Myers Squibb for Diastolic Heart Failure (HFpEF): Likelihood of Approval
21 Dec 2023 02:02 GMT
… of obstructive hypertrophic cardiomyopathy and diastolic heart failure (heart failure with preserved ejection …
-
CK-586 by Cytokinetics for Diastolic Heart Failure (HFpEF): Likelihood of Approval
05 Dec 2023 05:48 GMT
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role …
-
PF-07328948 by Pfizer for Diastolic Heart Failure (HFpEF): Likelihood of Approval
05 Dec 2023 05:48 GMT
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role …
-
Canagliflozin by Johnson & Johnson for Diastolic Heart Failure (HFpEF): Likelihood of Approval
05 Dec 2023 02:07 GMT
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role …
-
Aficamten by Cytokinetics for Diastolic Heart Failure: Likelihood of Approval
19 Nov 2023 01:39 GMT
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role …
-
YOUR HEALTH: Diastolic heart failure; trial puts novel device to the test
26 May 2023 13:35 GMT
COLUMBUS, Ohio (Ivanhoe Newswire) - Diastolic heart failure happens when the left ventricle, … out of breath.
Hamilton had diastolic heart failure, or DHF. The pumping chamber …
About
© 1995-2025